In vitro and in vivo effects of morin on the intestinal absorption and pharmacokinetics of olmesartan medoxomil solid dispersions

References

• Lee BS, Kang MJ, Choi WS, et al. Solubilized formulation of olmesartan medoxomil for enhancing oral bioavailability. Arch Pharm Res 2009;32:1629–35.
   PubMed Web of Science ®Google Scholar
• Bell AM, Nykamp D. Hypertension: focus on olmesartan medoxomil clinical medicine. Therapeutics 2009;1:1–9.
   Google Scholar
• Sengupta P, Nandi U, Kumar Pal T. Development of safety profile evaluating pharmacokinetics, pharmacodynamics and toxicity of a combination of pioglitazone and olmesartan medoxomil in Wistar albino rats. Regul Toxicol Pharmacol 2012;62:7–15.
   PubMed Web of Science ®Google Scholar
• Gorain B, Choudhury H, Kundu A, et al. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats. Colloids Surf B Biointerfaces 2014;115:286–94.
   PubMed Web of Science ®Google Scholar
• Yamada A, Maeda K, Kamiyama E, et al. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Drug Metab Dispos 2007;35:2166–76.
   PubMed Web of Science ®Google Scholar
• Nakagomi-Hagihara R, Nakai D, Kawai K, et al. OATP1B1, OATP1B3, and MRP2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker. Drug Metab Dispos 2006;34:862–9.
   PubMed Web of Science ®Google Scholar
• Shaikh SM, Avachat AM. Enhancement of solubility and permeability of candesartan cilexetil by using different pharmaceutical interventions. Curr Drug Deliv 2011;8:346–53.
   PubMed Web of Science ®Google Scholar
• Ramadhani N, Shabir M, McConville C. Preparation and characterization of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram. Int J Pharm 2014;475:514–22.
   PubMed Web of Science ®Google Scholar
• Mehanna MM, Motawaa AM, Samaha MW. In sight into tadalafil - block copolymer binary solid dispersion: mechanistic investigation of dissolution enhancement. Int J Pharm 2010;402:78–88.
   PubMed Web of Science ®Google Scholar
• Lutrol L. and Lutrol F grades, 2010. Technical information, BASF.
   Google Scholar
• Luo FR, Paranjpe PV, Guo A, et al. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters P-gp, CMOAT, and MRP 1. Drug Metab Dispos 2002;30:763–70.
   PubMed Web of Science ®Google Scholar
• Hunter J, Hirst BH. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv Drug Deliv Rev 1997;25:129–57.
   Web of Science ®Google Scholar
• Kunta JR, Sinko PJ. Intestinal drug transporters: in vivo function and clinical importance. Curr Drug Metab 2004;5:109–24.
   PubMed Web of Science ®Google Scholar
• Chan LM, Lowes S, Hirst BH. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 2004;21:25–51.
   PubMed Web of Science ®Google Scholar
• Lutful A. P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights 2013;7:27–34.
   PubMedGoogle Scholar
• Schellens JHM, Malingré MM, Kruijtzer CMF, et al. Modulation of oral bioavailability of anticancer drugs: from mouse to man. Eur J Pharm Sci 2000;12:103–10.
   PubMed Web of Science ®Google Scholar
• Jibodh RA, Lagas JS, Nuijen B, et al. Taxanes: old drugs, new oral formulations. Eur J Pharmacol 2013;717:40–6.
   PubMed Web of Science ®Google Scholar
• Lee K, Chae SW, Xia Y, et al. Effect of coumarin derivative-mediated inhibition of P-glycoprotein on oral bioavailability and therapeutic efficacy of paclitaxel. Eur J Pharmacol 2014;723:381–8.
   PubMed Web of Science ®Google Scholar
• Kagan L, Dreifinger T, Mager DE, Hoffman A. Role of P glycoprotein in region-specific gastrointestinal absorption of talinolol in rats. Drug Metabol Dispos 2010;38:1560–6.
   PubMed Web of Science ®Google Scholar
• Wessler JD, Grip LT, Mendell J, Giugliano RP. The P-glycoprotein transport system and cardiovascular drugs. J Am Coll Cardiol 2013;61:2495–502.
   PubMed Web of Science ®Google Scholar
• Collnot E-M, et al. Influence of vitamin E TPGS poly (ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. J Control Release 2006;111:35–40.
   PubMed Web of Science ®Google Scholar
• Gaikwad VL, Bhatiab MS. Polymers influencing transportability profile of drug. Saudi Pharm J 2013;21:327–35.
   PubMed Web of Science ®Google Scholar
• Zhang Y-j, Ma C-h, Lu W-l, et al. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo. Acta Pharmacol Sin 2005;26:1402–8.
   PubMed Web of Science ®Google Scholar
• Zhao W, Uehera S, Tanaka K, et al. Effects of polyoxyethylene alkyl ethers on the intestinal transport and absorption of rhodamine 123: a P-glycoprotein substrate by in vitro and in vivo studies. J Pharm Sci 2016;105:1526–34.
   PubMed Web of Science ®Google Scholar
• Abdallah HM, Al-Abd AM, Salah El-Dine R, El-Halawany AM. P glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: a review. J Adv Res 2015;6:45–62.
   PubMed Web of Science ®Google Scholar
• Bansal T, Manu J, Roop KK, Sushama T. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. J Pharm Pharm Sci 2009;12:46–78.
   PubMed Web of Science ®Google Scholar
• Aurade RM, Akbar SMD, Goud H, et al. Inhibition of P-glycoprotein ATPase and its transport function of Helicoverpa marmigera by morin, quercetin and phloroglucinol. Pest Bio Physio 2011;101:212–9.
   Web of Science ®Google Scholar
• Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum 1965;4:117–21.
   Google Scholar
• Govindarajan R, Nagarsenker MS. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system. J Pharm Pharmacol 2004;56:725–33.
   PubMed Web of Science ®Google Scholar
• Chiang PC, et al. In vitro and in vivo evaluation of amorphous solid dispersions generated by different bench-scale processes, using griseofulvin as a model compound. Aaps J 2013;15:608–17.
   PubMed Web of Science ®Google Scholar
• Gurunath S, Baswaraj N, Patil PA. Safety evaluation of naringenin upon experimental exposure on rat gastrointestinal epithelium for novel optimal drug delivery. Drug Deliv 2013;2014:1–13.
   Google Scholar
• Cho HJ, Park JW, Yoon IS, Kim DD. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int J Nanomed 2014;9:495–504.
   PubMed Web of Science ®Google Scholar
• Beg S, Katare OP, Saini S, et al. Solid self-nanoemulsifying systems of olmesartan medoxomil: Formulation development, micromeritic characterization, in vitro and in vivo evaluation. Powder Technol 2016;294:93–104.
   Web of Science ®Google Scholar
• Gibaldi M, Perrier D. Pharmacokinetics. 2nd edn. (Swarbrick J ed). New York: Marcel Dekker, Inc.; 1982.
   Google Scholar
• ICH-Q1A (R2). 2003. “ICH harmonized tripartite guideline,” Cover note for revision of Q1A(R) stability testing of new drug substances and products. Federal Register 2003;68:65717–65718.
   Google Scholar
• Sharma A, Jain CP. Preparation and characterization of solid dispersions of carvedilol with PVP K30. Res Pharm Sci 2010;5:49–56.
   PubMedGoogle Scholar
• The United State Pharmacopeia 30/NF 25. (2007). Asian Ed: the official compendia of standard. Rockville The United States Pharmacopeial Convection Inc; 621–720.
   Google Scholar
• ICH (Q2R1). Guideline on validation of analytical procedures: text and methodology. Proceedings of the International Conference on Harmonization; 2007; Geneva.
   Google Scholar
• Kola Sinac N, Kachrimanis K, Homsek I, et al. Solubility enhancement of desloratadine by solid dispersion in poloxamers. Int J Pharm 2012;436:161–70.
   PubMed Web of Science ®Google Scholar
• Abd-El Bary A, Louis D, Sayed S. Olmesartan medoxomil surface solid dispersion-based orodispersible tablets: formulation and in vitro characterization. J Drug Del Sci Tech 2014;24:665–72.
   Web of Science ®Google Scholar
• Lu Y, Park K. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drug. Int J Pharm 2013;453:198–214.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao C, Ding J, et al. A comparative study of linear, Y-shaped and linear-dendritic methoxy poly(ethylene glycol)-block-polyamidoamine-block-poly(l-glutamic acid) block copolymers for doxorubicin delivery in vitro and in vivo. Acta Biomater 2016;40:243–253.
   PubMed Web of Science ®Google Scholar
• Kumar Bhati L, Tiwari G, Tiwari R, Kumar V. Enhancement of complexation efficiency of meloxicam using binary and ternary solid systems: formulation considerations. Am J Drug Discov Dev 2012;2:17–31.
   Google Scholar
• Xu WJ, Xie HJ, Cao QR, et al. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers. Drug Deliv 2016;23:41–8.
   PubMed Web of Science ®Google Scholar
• Medarević DP, Kachrimanis K, Mitrić M, et al. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions. Pharm Dev Technol 2016;21:268–76.
   PubMed Web of Science ®Google Scholar
• Shi C, Tong Q, Fang J, et al. Preparation, characterization and in vivo studies of amorphous solid dispersion of berberine with hydrogenated phosphatidylcholine. Eur J Pharm Sci 2015;74:11–7.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Dorodnych TY, Klinskii EY, et al. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. Br J Cancer 1996;74:1545–52.
   PubMed Web of Science ®Google Scholar
• Batrakova E, Lee S, Li S, et al. Fundamental relationships between the compositions of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res 1999;16:1373–9.
   PubMed Web of Science ®Google Scholar
• Lassoed MA, Sfar S, Bouraoui A, Khemiss F. Absorption enhancement studies of clopidogrel hydrogen sulfate in rat everted gut sacs. J Pharm Pharmcol 2012;64:541–52.
   PubMed Web of Science ®Google Scholar
• Shen JY, Yang XL, Yang ZL, et al. Enhancement of absorption and bioavailability of echinacoside by verapamil or clove oil. Drug Des Devel Ther 2015;9:4685–93.
   PubMed Web of Science ®Google Scholar
• Kang MJ, Kim HS, Jeon HS, et al. In situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in self-microemulsifying drug delivery system. Drug Dev Ind Pharm 2012;38:587–96.
   PubMed Web of Science ®Google Scholar